Skip to content

Clinical effect of Yougui pill on diabetic osteoporosis

Clinical effect of Yougui pill on diabetic osteoporosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066020
Enrollment
Unknown
Registered
2022-11-22
Start date
2022-11-30
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic osteoporosis

Interventions

yougui pill group:Caltrate D Tablets + yougui pill
placebo group:Caltrate D Tablets + placebo pill

Sponsors

Panyu Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Male or female, aged 40-75 years; 2. Western medicine diagnosis meets the diagnostic criteria of type 2 diabetes mellitus and osteoporosis; 3. The patient conforms to the diagnosis of kidney Yang deficiency in traditional Chinese medicine; 4. The patients were in line with the order of diabetes followed by osteoporosis; 5. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with hyperparathyroidism, rheumatic diseases and other metabolic diseases affecting bone mineral density; 2. Patients with type I diabetes; 3. Substance (alcohol or drug) abuse or dependence in the past 3 months; 4. Patients who take glucocorticoids, proton pump inhibitors, and a large amount of calcium affect bone mineral density; 5. had participated in other drug clinical trials within 1 month before being included in this study.

Design outcomes

Primary

MeasureTime frame
Bone mineral density;

Secondary

MeasureTime frame
Bone mineral density four items;Glycosylated hemoglobin;TCM syndrome integration;

Countries

China

Contacts

Public ContactFeng yiran

Panyu Hospital of Traditional Chinese Medicine

fengyiran1983@163.com+86 13534883118

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026